Back to Markets
KZKazia Therapeutics Ltd

Kazia Therapeutics Ltd

KZIANASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$12.78

+0.1100 (+0.87%)

As of 05/29/26 EDT · USD

Compare
Low: $3.54Current: $12.78High: $17.40

Key Statistics

Open

$12.29

Day High

$13.32

Day Low

$12.29

Prev. Close

$12.67

VolumeShares traded today.

146.32K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$137.16M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.11

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$17.40

52W LowLowest price over the past 52 weeks.

$3.54

50D MAAverage closing price over the last 50 trading days.

$10.93

200D MAAverage closing price over the last 200 trading days.

$8.58

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-3.0%

1M

+2.9%

6M

-0.1%

YTD

+155.6%

1Y

+236.3%

About

Paul A. Hopper is an Australian bioentrepreneur who has been associated since 2003 with a number of biotechnology companies, most of them publicly traded.

www.kaziatherapeutics.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade KZIA

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.